Elasmogen is a startup based in the United Kingdom, 3 tracked investors.
Elasmogen is a startup founded in 2017 based in the United Kingdom. Brouky records 3 investors associated with the company.
Elasmogen is a biopharmaceutical company developing next-generation soloMER™ biologics. We specialize in high-affinity, site-specific treatments for solid-tumor cancers and inflammatory diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.